The channel hypothesis of Alzheimer's disease: current status - PubMed (original) (raw)
Review
The channel hypothesis of Alzheimer's disease: current status
Bruce L Kagan et al. Peptides. 2002 Jul.
Abstract
The channel hypothesis of Alzheimer's disease (AD) proposes that the beta-amyloid (Abeta) peptides which accumulate in plaques in the brain actually damage and/or kill neurons by forming ion channels. Evidence from a number of laboratories has demonstrated that Abeta peptides can form ion channels in lipid bilayers, liposomes, neurons, oocyctes, and endothelial cells. These channels possess distinct physiologic characteristics that would be consistent with their toxic properties. Abeta channels are heterogeneous in size, selectivity, blockade, and gating. They are generally large, voltage-independent, and relatively poorly selective amongst physiologic ions, admitting calcium ion (Ca(2+)), Na(+), K(+), Cs(+), Li(+), and possibly Cl(-). They are reversibly blocked by zinc ion (Zn(2+)), and tromethamine (tris), and irreversibly by aluminum ion (Al(3+)). Congo red inhibits channel formation, but does not block inserted channels. Although much evidence implicates Abeta peptides in the neurotoxicity of AD, no other toxic mechanism has been demonstrated to be the underlying etiology of AD. Channel formation by several other amyloid peptides lends credence to the notion that this is a critical mechanism of cytotoxicity.
Similar articles
- Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red.
Hirakura Y, Lin MC, Kagan BL. Hirakura Y, et al. J Neurosci Res. 1999 Aug 15;57(4):458-66. J Neurosci Res. 1999. PMID: 10440895 - Different effects of Alzheimer's peptide Aβ(1-40) oligomers and fibrils on supported lipid membranes.
Canale C, Seghezza S, Vilasi S, Carrotta R, Bulone D, Diaspro A, San Biagio PL, Dante S. Canale C, et al. Biophys Chem. 2013 Dec 1;182:23-9. doi: 10.1016/j.bpc.2013.07.010. Epub 2013 Aug 14. Biophys Chem. 2013. PMID: 23998637 - beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease.
Arispe N, Pollard HB, Rojas E. Arispe N, et al. Mol Cell Biochem. 1994 Nov 23;140(2):119-25. doi: 10.1007/BF00926750. Mol Cell Biochem. 1994. PMID: 7898484 Review. - Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes.
Bode DC, Baker MD, Viles JH. Bode DC, et al. J Biol Chem. 2017 Jan 27;292(4):1404-1413. doi: 10.1074/jbc.M116.762526. Epub 2016 Dec 7. J Biol Chem. 2017. PMID: 27927987 Free PMC article. - Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity.
Pollard HB, Arispe N, Rojas E. Pollard HB, et al. Cell Mol Neurobiol. 1995 Oct;15(5):513-26. doi: 10.1007/BF02071314. Cell Mol Neurobiol. 1995. PMID: 8719038 Review.
Cited by
- Leveraging Plasma Membrane Repair Therapeutics for Treating Neurodegenerative Diseases.
Bulgart HR, Goncalves I, Weisleder N. Bulgart HR, et al. Cells. 2023 Jun 18;12(12):1660. doi: 10.3390/cells12121660. Cells. 2023. PMID: 37371130 Free PMC article. Review. - Effect of β-amyloid on blood-brain barrier properties and function.
Petrushanko IY, Mitkevich VA, Makarov AA. Petrushanko IY, et al. Biophys Rev. 2023 Apr 5;15(2):183-197. doi: 10.1007/s12551-023-01052-x. eCollection 2023 Apr. Biophys Rev. 2023. PMID: 37124923 Free PMC article. Review. - Dendrimers in Alzheimer's Disease: Recent Approaches in Multi-Targeting Strategies.
Arbez-Gindre C, Steele BR, Micha-Screttas M. Arbez-Gindre C, et al. Pharmaceutics. 2023 Mar 10;15(3):898. doi: 10.3390/pharmaceutics15030898. Pharmaceutics. 2023. PMID: 36986759 Free PMC article. Review. - Distinct Effects of Beta-Amyloid, Its Isomerized and Phosphorylated Forms on the Redox Status and Mitochondrial Functioning of the Blood-Brain Barrier Endothelium.
Petrovskaya AV, Tverskoi AM, Barykin EP, Varshavskaya KB, Dalina AA, Mitkevich VA, Makarov AA, Petrushanko IY. Petrovskaya AV, et al. Int J Mol Sci. 2022 Dec 22;24(1):183. doi: 10.3390/ijms24010183. Int J Mol Sci. 2022. PMID: 36613623 Free PMC article. - Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer's Disease.
Kabir ER, Chowdhury NM, Yasmin H, Kabir MT, Akter R, Perveen A, Ashraf GM, Akter S, Rahman MH, Sweilam SH. Kabir ER, et al. Curr Neuropharmacol. 2023;21(4):787-807. doi: 10.2174/1570159X20666221010113812. Curr Neuropharmacol. 2023. PMID: 36221865 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous